ProShare Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
|
|||||
|
2025
Q1 | $398K | Sell |
|
|||||
|
2024
Q4 | $442K | Buy |
|
|||||
|
2024
Q3 | $258K | Buy |
|
|||||
|
2024
Q2 | $119K | Sell |
|
|||||
|
2024
Q1 | $142K | Buy |
|
|||||
|
2023
Q4 | $152K | Buy |
|
|||||
|
2023
Q3 | $128K | Buy |
|
|||||
|
2023
Q2 | $220K | Buy |
|
|||||
|
2023
Q1 | $264K | Sell |
|
|||||
|
2022
Q4 | $278K | Buy |
|
|||||
|
2022
Q3 | $298K | Buy |
|
|||||
|
2022
Q2 | $285K | Sell |
|
|||||
|
2022
Q1 | $454K | Sell |
|
|||||
|
2021
Q4 | $669K | Buy |
|
|||||
|
2021
Q3 | $496K | Sell |
|
|||||
|
2021
Q2 | $379K | Buy |
|
|||||
|
2021
Q1 | $568K | Buy |
|
|||||
|
2020
Q4 | $510K | Buy |
|
|||||
|
2020
Q3 | $262K | Buy |
|
|||||
|
2020
Q2 | $256K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $212K | Sell |
|
|||||
|
2019
Q3 | $189K | Sell |
|
|||||
|
2019
Q2 | $331K | Sell |
|
|||||
|
2019
Q1 | $420K | Buy |
|
|||||
|
2018
Q4 | $415K | Sell |
|
|||||
|
2018
Q3 | $616K | Sell |
|
|||||
|
2018
Q2 | $601K | Sell |
|
|||||
|
2018
Q1 | $523K | Sell |
|
|||||
|
2017
Q4 | $566K | Buy |
|
|||||
|
2017
Q3 | $604K | Buy |
|
|||||
|
2017
Q2 | $445K | Sell |
|
|||||
|
2017
Q1 | $449K | Sell |
|
|||||
|
2016
Q4 | $582K | Buy |
|
|||||
|
2016
Q3 | $598K | Sell |
|
|||||
|
2016
Q2 | $565K | Buy |
|
|||||
|
2016
Q1 | $428K | Sell |
|
|||||
|
2015
Q4 | $659K | Buy |
|
|||||
|
2015
Q3 | $620K | Sell |
|
|||||
|
2015
Q2 | $1.07M | Buy |
|
|||||
|
2015
Q1 | $609K | Buy |
|
|||||
|
2014
Q4 | $272K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $122K | Buy |
|